Previous 10 | Next 10 |
The shares of MedTech company Ra Medical Systems, Inc. ( NYSE: RMED ) added ~37% in the pre-market trading Monday on the announcement of a merger agreement with Catheter Precision, a medical device developer focused on cardiac electrophysiology procedures. Per the term...
Combined Company Dedicated to Developing and Delivering Novel Technologies and Solutions to Improve the Lives of Patients with Cardiac Arrhythmias M edtech Veteran David Jenkins to Lead Merged Company Ra Medical Systems, Inc. (NYSE American: RMED) (...
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that on August 31, 2022, it received a notice (the “Notice”) that the NYSE American LLC has determined the Company’s securities have been selling at a low pr...
Ra Medical Systems press release ( NYSE: RMED ): Q2 GAAP EPS of -$0.26. Ra Medical reported cash and cash equivalents of $11.1 million as of June 30, 2022. For further details see: Ra Medical Systems GAAP EPS of -$0.26
Ra Medical Systems, Inc . (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and six months ended June 30, 2022 and provides a business update. “We are continuing to pursue a potential merger with a pr...
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company’s Form 10-K filed with the Securities and Exchange C...
Ra Medical Systems ( NYSE: RMED ) announced a reduction in exercise price of all existing warrants (February 2022 issued) consisting of Series A Warrants and Series B Warrants, from $0.50/share to $0.28/share, and entry into a non-binding term sheet to merge with pri...
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces a reduction in the exercise price of all existing warrants that were issued in the February 2022 public offering, consisting of Series A Warrants and Series B Warrants, from $0.5...
Ra Medical Systems ( NYSE: RMED ) appointed Brian D. Conn as interim CFO, effective immediately, replacing interim CFO Will McGuire who was appointed on July 8 after the departure of Andrew Jackson on May 25, 2022; he will serve as Principal Financial Officer an...
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the appointment of Brian D. Conn as interim Chief Financial Offi...
News, Short Squeeze, Breakout and More Instantly...
Ra Medical Systems Inc. Company Name:
RMED Stock Symbol:
NYSE Market:
Ra Medical Systems Inc. Website:
Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced that its Board of Directors has approved cha...
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Ent...
Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures FORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricula...